Novo's Wegovy pill tracks over 38,000 prescriptions in fifth week

Core Insights - Novo Nordisk's Wegovy pill achieved 38,220 U.S. prescriptions in the fifth week following its launch, indicating strong initial demand for the product [1] Company Performance - The data from IQVIA suggests that Wegovy is gaining traction in the market shortly after its introduction, reflecting positive reception among healthcare providers and patients [1]